SEC Filings for ImmunoGen Inc. (IMGN)

$ 4.92   0.24 (+5.13%) Volume: 2.58m 4:00 PM EDT 1-Jun-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)5805/05/2020
8-KCurrent report pursuant to Section 13 or 15(d)905/01/2020
CT ORDERConfidential treatment order104/30/2020
DEF 14AOther definitive proxy statements4704/28/2020
DEFA14AAdditional proxy soliciting materials - definitive604/28/2020
PRE 14APreliminary proxy statement providing notification matters to be brought to a vote4704/17/2020
4Statement of changes in beneficial ownership of securities104/02/2020
4Statement of changes in beneficial ownership of securities104/02/2020
4Statement of changes in beneficial ownership of securities104/02/2020
10-KAnnual report pursuant to Section 13 or 15(d)12903/11/2020
4Statement of changes in beneficial ownership of securities102/25/2020
4Statement of changes in beneficial ownership of securities102/25/2020
4Statement of changes in beneficial ownership of securities102/25/2020
4Statement of changes in beneficial ownership of securities102/25/2020
4Statement of changes in beneficial ownership of securities102/25/2020
<<
First
<
Prev
123456789101112131415